IP Australia has recently launched a set of interactive patent analytics displays related to technologies instrumental in the fight against COVID-19. These provide researchers and decision-makers with valuable tools to locate key intelligence within the body of patent information around these subjects.
IP Australia Patent Analytics Hub
IP Australia’s Patent Analytics Hub is an initiative that has grown out of the Office of the Chief Economist (OCE). Originally focussed on economics research, the OCE has evolved to include open data products and patent information as part of its research services.
The Patent Analytics Hub delivers patent analytics to customers including research organisations and government agencies. The reports support customers in identifying opportunities, monitoring competitor and market activity, determining the value of their intellectual assets, and guiding business decisions.
COVID-19 Technology Visualisations
As part of the global effort against the COVID-19 pandemic, the Patent Analytics Hub has developed a set of six freely-available interactive visualisations.
The visualisations cover:
- Surgical gowns and goggles
- Repurposed drugs
- Medical diagnostics
Beginning with a top-level summary and overview of each analysis, users can then view the data as a series of interactive charts and graphs. These can be drilled into and filtered to view the results for specific regions, applicants, and filing periods. Once a document or documents are identified, the user can hyperlink directly to view full details of any patent of interest.
This resource will enable researchers and decision-makers to identify potentially useful technology, as well as the relevant patents and their owners. This can assist in identifying know-how, partners, suppliers and manufacturers to gain a stronger position in the fight against COVID-19.
Global Collaborative Efforts
This initiative from IP Australia is just one of many such approaches around the world to support the sharing of innovative knowledge and technology.
WIPO (the World Intellectual Property Organisation) has launched a new search function for its PATENTSCOPE database to assist in the identification of relevant patent documents that may be of value in the fight against COVID-19. CAS (the Chemical Abstracts Service) has released an open-access dataset of compounds having known or potential antiviral activity, to assist research and analytics efforts.
The Open COVID Pledge is an initiative to encourage more open access to intellectual property in the fight against COVID-19. Examples of companies supporting the pledge and making their portfolios of thousands of patents available to the world include Intel and Microsoft, amongst others.
Further, Pfizer and BioNTech are working together to jointly develop a COVID-19 vaccine. BioNTech has provided multiple vaccine candidate compounds, whilst Pfizer has provided access to its research and development, regulatory, manufacturing, and distribution infrastructure. Initial human trials are already underway.
By working together, we have a much better chance of defeating this common enemy. Maybe the lessons learned can provide the impetus for more collaborative approaches in the future.
CAS. (2020, March 31). “CAS Releases Open Access Dataset of Antiviral Chemical Compounds to Aid COVID-19 Discovery and Analysis”. Retrieved May 16, 2020, from: https://www.cas.org/resources/press-releases/open-access-covid-19-dataset
CSR Admin. (2020, April 07). “Intel Grants Free Access to Its Intellectual Property to COVID-19 Researchers and Scientists”. Retrieved May 16, 2020, from: https://blogs.intel.com/csr/2020/04/open-covid-pledge/#gs.6mv966
IP Australia. (2020). “Australian Intellectual Property Report 2020 – Chapter 8: Research Program”. Retrieved May 13, 2020, from: https://www.ipaustralia.gov.au/ip-report-2020/research-program
IP Australia. (2020, May 06). “New patent visualisations on the latest COVID-19 technology”. Retrieved May 12, 2020, from: https://www.ipaustralia.gov.au/about-us/news-and-community/news/new-patent-visualisations-latest-covid-19-technology
IP Australia. (2020, May 06). “Patent Analytics Hub”. Retrieved May 12, 2020, from: https://www.ipaustralia.gov.au/tools-resources/patent-analytics-hub
Open COVID Pledge. (2020, April 07). “Open COVID Pledge”. Retrieved May 16, 2020, from: https://opencovidpledge.org/
Pfizer. (2020, April 09). “Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development”. Retrieved May 16, 2020, from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_announce_further_details_on_collaboration_to_accelerate_global_covid_19_vaccine_development
Pfizer. (2020, May 05). “Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program”. Retrieved May 16, 2020, from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_dose_first_participants_in_the_u_s_as_part_of_global_covid_19_mrna_vaccine_development_program
Szweras M, De Luca C. (2020, April 22). “Patents and Their Role in a COVID-19 Cure”. Retrieved May 13, 2020, from: https://www.lexology.com/library/detail.aspx?g=b757a56e-834f-433f-b548-80fa98b7574d
World Intellectual Property Organisation. (2020, April 21). “WIPO Launches New Search Facility For PATENTSCOPE Database to Support COVID-19 Innovation Efforts”. Retrieved May 16, 2020, from: https://www.wipo.int/pressroom/en/articles/2020/article_0008.html
Yokoyama J. (2020, April 20). “Microsoft commits patents to help fight COVID-19”. Retrieved May 13, 2020, from: https://blogs.microsoft.com/on-the-issues/2020/04/20/open-covid-19-pledge-patents/